Specialized Implantable Cellular and Biotherapeutic Agent Delivery Canisters for Niche Environments

Publication ID: 24-11857670_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Implantable Cellular and Biotherapeutic Agent Delivery Canisters for Niche Environments,” Published Technical Disclosure No. 24-11857670_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857670_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,670.

Summary of the Inventive Concept

A family of implantable canisters tailored for specific, high-stakes environments, such as disaster relief, high-security biocontainment, extreme weather conditions, high-altitude implantation, and underwater implantation.

Background and Problem Solved

The original implantable cellular and biotherapeutic agent delivery canister, while effective for general therapeutic applications, has limitations when applied to unique operational environments. The new inventive concept addresses these limitations by adapting the canister design to cater to specific niche markets, ensuring reliable and controlled delivery of therapeutically active agents in challenging situations.

Detailed Description of the Inventive Concept

The new inventive concept encompasses four specialized canister designs: (1) a disaster relief canister with enhanced biocompatibility and rapid agent diffusion; (2) a high-security biocontainment canister with advanced metallurgic materials and tamper-evident features; (3) an extreme weather condition canister with enhanced thermal resistance and shock-absorbing properties; (4) a high-altitude implantation canister with optimized internal pressure regulation; and (5) an underwater implantation canister with waterproof coatings and corrosion-resistant materials. Each design variation leverages the original canister's nanoscale through-porous structure and metallic material shell, while incorporating unique features to address the specific challenges of its target environment.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original canister design to cater to specific, high-stakes environments. The inventive step lies in the application of the original canister's principles to these niche markets, resulting in a family of specialized canisters that address previously unmet needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include canisters designed for space exploration, high-radiation environments, or applications requiring advanced encryption and data storage. Variations could also involve the integration of sensors, microelectronics, or other technologies to enhance the canisters' functionality and adaptability.

Potential Commercial Applications and Market

The specialized implantable canisters have significant commercial potential in various industries, including disaster relief, biodefense, environmental monitoring, and aerospace. Target markets may include government agencies, research institutions, and private companies operating in these sectors.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61F2/022
A A61 A61K31/337
A A61 A61K31/397
A A61 A61K31/436
A A61 A61K31/65
A A61 A61K31/7036
A A61 A61K35/28
A A61 A61K38/14
A A61 A61K38/1866
A A61 A61K38/22
A A61 A61K39/395
A A61 A61K47/02
A A61 A61M39/0247
A A61 A61M2039/027
A A61 A61M2039/0261
A A61 A61M2039/0276
A A61 A61M2205/04

Original Patent Information

Patent NumberUS 11,857,670
TitleImplantable cellular and biotherapeutic agent delivery canister
Assignee(s)NanoVault Medical LLC